Transcriptional reprogramming in neonatal hematopoietic stem and progenitor cells

Area of Science:

• Hematology
• Developmental Biology
• Cancer Biology

Background:

• Hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) exhibit significant gene expression changes from neonatal to juvenile stages.
• These temporal gene expression shifts impact HSC self-renewal, lineage commitment, and hematopoietic output, potentially influencing disease phenotypes like childhood leukemia.

Purpose of the Study:

• To explore the mechanistic details of how HSCs transition from fetal to adult transcriptional states.
• To understand the implications of uncoordinated and imprecisely timed developmental gene expression shifts in HSCs/HPCs.
• To investigate the role of type I interferon signaling in this transition and its link to leukemogenesis.

Main Methods:

• This perspective piece synthesizes recent research findings.
• It reviews studies on gene regulatory networks governing HSC/HPC development.
• It discusses the impact of developmental timing and signaling pathways on cell fate.

Main Results:

• The transition of HSCs/HPCs from fetal to adult transcriptional states is uncoordinated and imprecisely timed.
• Type I interferon signaling plays a crucial role, activating adult-like gene expression and potentially sensitizing cells to mutations shortly after birth.
• This prolonged transition period may allow neonatal HSCs and HPCs to acquire adult properties gradually.

Conclusions:

• Understanding the developmental modulation of HSC/HPC fate is critical for comprehending normal hematopoiesis and childhood blood disorders.
• The imprecisely timed developmental switch and associated interferon signaling may represent a window of vulnerability for leukemogenesis.
• Targeting these developmental switches could offer novel strategies for treating or preventing childhood leukemias.